18F-GPI

N/A

Report date: 2026/02/27 20:01:47

Base Information

Drug Name18F-GPI
Drug Alias Name18F-GPIF18-GP1GP1-F18GP1-18F[18F]GP1 +[6] 
ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radionuclide Drug Conjugates +[5] 
Mechanisms of ActionPositron-emission tomography enhancersIonising radiation emittersIntegrin alpha-IIb/beta-3 antagonists
TargetsIntegrin alpha-IIb/beta-3
Therapy Area/IndicationsVenous ThrombosisAortic Aneurysm, Abdominal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerlandSouth Korea
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesAsan Medical Center
Inactive CompaniesUniversity of Zurich
Active IndicationsVenous Thrombosis
Inactive IndicationsAortic Aneurysm, Abdominal

Other Information

ATC CodeN/A
Related LinksN/A